magnesium hydroxide 200 MG
RxNorm concept 316201, clinical drug component (scdc).
- RxCUI
- 316201
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/316201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 25 MG Chewable Tablet [Gelusil] (SBD, constitutes)
- aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 25 MG Chewable Tablet [Mintox Plus] (SBD, constitutes)
- aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 25 MG Chewable Tablet (SCD, constitutes)
- calcium carbonate 1000 MG / magnesium hydroxide 200 MG Chewable Tablet (SCD, constitutes)
- calcium carbonate 1000 MG / magnesium hydroxide 200 MG Chewable Tablet [Rolaids Reformulated Aug 2006] (SBD, constitutes)
- calcium carbonate 1000 MG / magnesium hydroxide 200 MG / simethicone 40 MG Chewable Tablet (SCD, constitutes)
- magnesium hydroxide (IN, has ingredient)
- aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 25 MG [Gelusil] (SBDC, has tradename)
- aluminum hydroxide 200 MG / magnesium hydroxide 200 MG / simethicone 25 MG [Mintox Plus] (SBDC, has tradename)
- calcium carbonate 1000 MG / magnesium hydroxide 200 MG [Rolaids Reformulated Aug 2006] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 316201 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/316201 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 316201. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.